Fully Integrated Multiplex PCR Platform

The agency is seeking a fully integrated multiplex PCR platform permitted for research as a point-of-use system that also functions in public health laboratories for rapid syndromic testing of infectious diseases. The desired platform must solve the problem of lengthy sample processing times by automating a number of PCR-related processes to enable researchers or medical laboratory scientists to work more efficiently. The system must provide scientifically defensible molecular-based microbial identifications and determine the presence or absence of several health-relevant antimicrobial resistance genes. The scope of work requires a platform capable of running at least four samples simultaneously within one hour. The system must utilize a single kit or a variety of kits that can test for 40 or more targets, including at least 20 bacterial, five yeast, and 10 antibiotic resistance genes from blood culture. The agency requires platforms with developed kits that have documented use in scientific literature. Only onshore organizations based in the United States are eligible to bid on this opportunity. The selected provider will perform all work offsite. Bidders must submit their responses digitally via email or through the online system. The agency is currently looking for proposals to determine the budget for this project, and no specific key dates are provided in the sourcing details.